Historical reason: the original 503A and 503B compounding pharmacies that started compounding semaglutide in 2022 used B12 as a "marker" so patients and providers could visually distinguish their compounded product from FDA-approved Ozempic, which is always clear
Circ Res 2019, 124(2): 315-327
Over time, it slows down the speed at which food leaves your stomach, causing you to feel full sooner and longer
These may include a 24-hour liquid diet, gastric ultrasound, or procedure delay
The GLP-1 foundation: Semaglutide Semaglutide is a GLP-1 medication that mimics the GLP-1 incretin hormone produced in the intestines
One notable benefit is the improvement in heart health, achieved by reducing excess weight, which in turn eases the strain on arteries and reduces stress on the heart